Resources

Recombinase Polymerase Amplification (RPA) assays were designed to detect pol from HIV-1BRU proviral DNA using real-time or immunochromatographic strip detection of RPA amplicons. Presented at: AACC 41st Annual Oak Ridge Conference, April 16, 2009; Baltimore, MD.

This newsletter provides an overview of programs within and outside of India that are converging or integrating sexual and reproductive health (SRH) and HIV/AIDS services. It also shares some of the successes, challenges, and best practices emerging from these programs. It is available in two formats: one for onscreen viewing and one for booklet-style printing.

This is part of a series of working draft documents that discuss key questions and preliminary findings of PATH’s Safe Water Project. These reports will be used to inform follow-on research, identify potential partners, and contribute to the development of pilot activities. This particular document reports on “snapshot” research that PATH commissioned in 2007 on the safe water situation in Cambodia, Ghana, Tanzania, and Vietnam.

This document presents new research results from PATH's HPV Vaccines: Evidence for Impact project in Peru. PATH is working with ministries of health and other country partners to develop strategies for introducing vaccines against human papillomavirus (HPV), the primary cause of cervical cancer.

This document presents new research results from PATH's HPV Vaccines: Evidence for Impact project in Uganda. PATH is working with ministries of health and other country partners to develop strategies for introducing vaccines against human papillomavirus (HPV), the primary cause of cervical cancer.